<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="Health Science 1916-9736 1916-9744 Canadian Center of Science and Education" exact="Canada" post="pmcid: 4776863 pmid: 23777736 GJHS-5-200 doi: 10.5539/gjhs.v5n4p200 : Articles"/>
 <result pre="and second-line injectable drugs, was found in 2006 KwaZulu Natal," exact="South Africa." post="It spread rapidly among HIV immunocompromised patients and was"/>
 <result pre="al., 1997). The findings of a recent prospective study in" exact="Uganda" post="provide evidence that the standard retreatment approach to TB,"/>
 <result pre="which stands at 18–24 months. A recent observational study in" exact="Bangladesh" post="showed that a short, standardized treatment regimen based on"/>
 <result pre="the most basic surveillance ( WHO, 2009). By 2010, only" exact="South Africa" post="had the capacity to diagnose MDR-TB and XDR-TB ("/>
 <result pre="line with individualized treatment regimens based on DST results. In" exact="Peru" post="a cohort of MDR-TB patients treated with a fully"/>
 <result pre="Africa. Noeske et al. (2012) undertook a pilot programme in" exact="Cameroon" post="aimed at performing routine DST among previously treated pulmonary"/>
 <result pre="also showed limited infection control practices in clinics in KwaZulu-Natal," exact="South Africa." post="Naidoo, Seevnarain and Nordstrom (2012) found that of 51"/>
 <result pre="a baseline triage and separation strategy has been implemented in" exact="Haiti" post="depending on smear results and HIV status (Institute of"/>
 <result pre="and to patients undergoing procedures to stimulate coughing. In the" exact="Nigeria" post="study, none of the facilities had health education materials,"/>
 <result pre="even in fairly wind-still condition (Escombe et al., 2010). In" exact="South Africa," post="an epidemiological mathematical modelling study showed that improvements to"/>
 <result pre="staff. Confirmatory evidence of UVGI efficacy against human-generated TB in" exact="Peru" post="and in South Africa highlights its potential role in"/>
 <result pre="of UVGI efficacy against human-generated TB in Peru and in" exact="South Africa" post="highlights its potential role in facilities that provide MDR/XDR"/>
 <result pre="A study conducted in specialized airborne infections research facility in" exact="South Africa," post="revealed that when infectious patients with MDR-TB wore surgical"/>
 <result pre="MDR-TB management. Provided that findings from the landmark study in" exact="Bangladesh" post="in a mostly HIV-negative setting can be replicated in"/>
 <result pre="co-infected with tuberculosis and HIV in a rural area of" exact="South Africa" post="Lancet 2006 368 1575 1580 http://dx.doi.org/10.1016/S0140-6736(06)69573-1 17084757 Harries A."/>
 <result pre="F. M. High early death rate in tuberculosis patients in" exact="Malawi" post="Int JTuberc Lung Dis 2001 5 11 1000 5"/>
 <result pre="Tuberculosis infection control in primary health clinics in eThekwini, KwaZulu-Natal," exact="South Africa" post="Int JTuberc Lung Dis 2012 16 12 1600 4"/>
 <result pre="systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in" exact="Cameroon" post="BMC Res Notes 2012 5 160 http://dx.doi.org/10.1186/1756-0500-5-160 22436423 Ogbonnaya"/>
 <result pre="services in &quot;German Leprosy and Tuberculosis Relief Association&quot; supported states" exact="Niger" post="JClin Pract 2011 14 3 270 5 http://dx.doi.org/10.4103/1119-3077.⇤5 22037066"/>
 <result pre="treatment for chronic tuberculosis patients: a national cohort study in" exact="Peru" post="Lancet 2002 359 9322 1980 9 http://dx.doi.org/10.1016/S0140-6736(02)08830-X 12076553 collab:"/>
 <result pre="1980 9 http://dx.doi.org/10.1016/S0140-6736(02)08830-X 12076553 collab: USAID HIV/AIDS health profile for" exact="Haiti" post="2010 collab: USAID East Africa; Tuberculosis profile 2010 Van"/>
</results>
